This analysis revealed that while GLP-1R, SLC25A6, and SLC9A9 showed consistent alterations across both diseases relative to controls (Figures 2a–c), SLC37A1 exhibited more specific changes to AD (Figure 2d). Here, SLC25A6 is linked to Alzheimer disease.